Abstract
The killing of human glioma by lymphokine activated killer (LAK) cells was studied. LAK cells generated by culturing recombinant interleukin-2 (ILr2) with human peripheral blood lymphocytes (PBL) obtained from normal volunteers markedly lysed allogeneic glioma grown in tissue culture. Susceptibility of glioma to lysis by LAK cells was abrogated by pretreating the glioma cells with trypsin or chymotrypsin, but was unaffected by pretreatment with hydrocortisone, neuraminidase, glycosidases or sodium periodate. These results suggest that the cell surface determinant on human glioma cells responsible for its tumor selective lysis by LAK is a protein sensitive to trypsin and chymotrypsin.
Similar content being viewed by others
References
Walker MD, Alexander Jr E, Hunt WE, Mc Carty CS, Mahaley MS, Mealy J, Norrell HA, Owens G, Ransohoff J, Nilson CB, Gehan EA, Stroke TA: Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomas. A cooperative clinical trial. J Neurosurg 49: 333–342, 1978.
Walker MD, Green SB, Byar DP, Alexander JE, Batzdorf U, Brooke WH, Hunt WE, Mc Carty CS, Mahaley MS, Mealey J, Owens G, Ransohoff J, Robertson JT, Shapiro WR, Smith KR, Wilson CB, Strike TA: Randomized comparisons of radiotherapy and nitrosourea for the treatment of malignant glioma after surgery. New Engl J Med 303:1323–1329, 1980.
Grimm EA, Mazumder A, Zhang HZ, Rosenberg SA: Lymphokine activated killer cell phenomenon lysis of natural interleukin-2-activated autologous human peripheral blood lymphocytes. J Exp Med 155:1823–1841, 1982.
Jacobs SK, Kornblith PL, Wilson DJ, Grimm EA: In vitro killing of human glioblastoma by interleukin-2 activated autologous lymphocytes. J Neurosurg 64:114–117, 1986.
Rosenberg SA, Grimm EA, McCrogan N, Doyle M, Kawasaki E, Koths K, Mark DF: Biologic activity of recombinant human interleukin-2 produced in E. coli. Science 223, 1412, 1984.
Weinstein RS, Kornblith PL: Ultrastructure of a cloned astrocytoma in tissue culture. Cancer 27:1174–1181, 1971.
Dohan FC, Kornblith PL, Wellum GR, Pfeiffer SF, Levine L: S-100 protein and 2′,3′-cyclic nucleotide 3′-phosphohydrolase in human brain tumors. Acta Neuropathol (Berl) 40:123–128, 1977.
Trachtenberg MC, Kornblith PL, Hauptli J: Biophysical properties of cultured human glial cells. Brain Res 38:279–298, 1972.
Aynard-Henry M, Coleman MT, Dowdle WR, Lauer WG, Schild GC, Webster RG: Influenza neuraminidase and neuraminidase-inhibition test procedures. Bull Wld Hlth Org 48:199–202, 1973.
Burnet FM, Anderson SG: ‘T’ antigen of guinea-pig and human red cells. Australian J Exptl Biol Med Sci 25:213–217, 1947.
Gesner BM, Ginsberg V. Effect of glycosidases on the fate of transfused lymphocytes. Proc Nat Acad Sci USA 52:750–755, 1974.
Gasic G, Gasic T. Removal of PAS positive surface surgars in tumor cells by glycosidases. Proc Soc Exptl Biol Med 114:660–663, 1963.
Sedlacek HH, Seiler FR: Immunotherapy of neoplastic diseases with neuraminidase: Contraindications, new aspects, and revised concepts. Cancer Immunol Immunother 5:153–163, 1978.
Ravid A, Novogrodsky A: Kinetics of the induction of DNA synthesis in lymphocytes by periodate. Exptl Cell Res 97:1–5, 1976.
Schlager SI, Ohanian SH: Role of membrane lipids in the immunological killing of tumor cells: I. Target cell lipids. Lipids 18:475–482, 1983.
Gromkowski SH, Heagy W, Martz E: Blocking of the CTL-mediated killing by monoclonal antibodies to LFA-1 and Lyt-2,3. II. Evidence that trypsin pretreatment of target cells removes a non-H-2 molecule important in killing. J Immunol 134:70–77, 1985.
Grimm EA, Ramsey KM, Mazumder A, Wilson DJ, Djeu JY, Rosenberg SA: Lymphokine-activated killer cell phenomenon. II. Precursor phenotype is serologically distinct from peripheral T lymphocytes, memory cytotoxic thymus-derived lymphocytes, and natural killer cells. J Exp Med 157:884–897, 1983.
Jacobs SK, Wilson DJ, Kornblith PL, Grimm EA: Interleukin-2 or autologous lymphokine activated killer cell treatment of malignant glioma: Phase I trial. Cancer Res 46:2101–2104, 1986.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Jacobs, S.K., Parham, C.W., Holcomb, B. et al. Lymphokine activated killer (LAK) cell mediated killing of human glioma: Effect of pretreating glioma with various membrane modifying agents. J Neuro-Oncol 5, 5–10 (1987). https://doi.org/10.1007/BF00162760
Issue Date:
DOI: https://doi.org/10.1007/BF00162760